AR037233A1 - Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento - Google Patents

Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento

Info

Publication number
AR037233A1
AR037233A1 ARP020103213A ARP020103213A AR037233A1 AR 037233 A1 AR037233 A1 AR 037233A1 AR P020103213 A ARP020103213 A AR P020103213A AR P020103213 A ARP020103213 A AR P020103213A AR 037233 A1 AR037233 A1 AR 037233A1
Authority
AR
Argentina
Prior art keywords
optionally substituted
group
alkyl
formula
hydrogen
Prior art date
Application number
ARP020103213A
Other languages
English (en)
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of AR037233A1 publication Critical patent/AR037233A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Abstract

Un compuesto piridina aril sustituida que tiene la fórmula (1), o una sal, profármaco o solvato farmacéuticamente aceptable del mismo, en donde: Ar se selecciona entre el grupo que consiste en Ar1, Ar2, Ar3 y Ar4, en donde; Ar1 es de fórmula (2); Ar2 es de fórmula (3); Ar3 es de fórmula (4); Ar5 es de fórmula(5);R1 se selecciona entre el grupo que consiste en un alquilo opcionalmente sustituido, amino, alquiltiol, C(O)R10, SO2R10, OC(O)NH2, 2-imidazolinilo, 2-imidazolilo, 3-pirazolilo, 5-isoxazolilo y 3-(1,2,4)-triazolilo; R2, R3 y R4 se selecciona en forma independiente entre el grupo que consiste en hidrógeno, alquilo, alquenilo o alquinilo opcionalmente sustituido, halógeno, hidroxi, cicloalquilo, ciano, amino, alquilamino, dialquilamino, alcoxi, aminocarbonilo, alquilaminocarbonilo, arilaminocarbonilo, aralquilaminocarbonilo, alquilcarbonilamino, arilcarbonilamino y aralquilcarbonilamino; siempre y cuando que 1) el anillo piridilo no sea 2,6-disustituido con respecto a Ar y R1, o cualquiera de R2-R4 que no es hidrógeno; y 2) cuando Ar es Ar2 o Ar3, entonces R1 es C(O)R10; 3) cuando Ar es Ar4, entonces R1 es aminocarbonilo o un heterocicloalquilaminocarbonilo opcionalmente sustituido; R5, R6, R7 y R8 se seleccionan en forma independiente entre el grupo que consiste en hidrógeno, alquilo, alquenilo, alquinilo, halógeno, haloalquilo, hidroxialquilo, hidroxi, nitro, amino, ciano, amida, carboxialquilo, alcoxialquilo, ureído, acilamino, tiol, aciloxi, azido, alcoxi, carboxi, carbonilamido y alquiltiol; R9 es un alquilo opcionalmente sustituido; R10 se selecciona entre el grupo que consiste en alquilo, alquenilo, alquinilo, OR11, amino, alquilamino, dialquilamino, alquenilamino, dialquilaminoalquenilo, dialquilaminoalquilamino, dialquilaminoalquenilamino, alquilaminoalquenilamino, hidroxiaminoalquenilamino, cicloalquilo, heterocicloalquilo, cicloalquilalquilamino, heterocicloalquilamino, arilo, arilalquilo, arialquenilo, arilalquinilo y arilalquilamino, todos los cuales pueden ser opcionalmente sustituidos, siempre y cuando que R10 no sea OR11 cuando R1 es SO2R10; en donde R11 se selecciona entre el grupo que consiste en hidrógeno, alquilo, opcionalmente sustituido y un metal alcalino; y X es uno de O, S, NH, o CH2 cuando Ar es Ar1; o X es una de O, S, NH, o está ausente (un enlace covalente) cuando Ar es Ar4, con las condiciones de que : 4) cuando Ar es Ar1, X es O, R5, R6 y R7 es cada uno hidrógeno, y R1 es un grupo alquilo, entonces R8 no es un grupo alcoxi opcionalmente sustituido; y 5) cuando Ar es Ar4, y X es O ó está ausente y R1 es aminocarbonilo, entonces R9 no es grupo alquilo de cadena recta opcionalmente monosustituido con halógeno, carboxi, alcoxi, un fenilo opcionalmente sustituido, o un aminocarbonilo opcionalmente sustituido. Además está dirigida a composiciones farmacéuticas y al uso de compuestos de la fórmula (1) para la elaboración de medicamentos para el tratamiento de dano neuronal como consecuencia de isquemia global y focal, para el tratamiento o prevención de condiciones neurodegenerativas tales como esclerosis lateral amiotrófica (ELA) y para el tratamiento, prevención o mejoría tanto de dolor agudo como crónico, como agentes antitinnitus, como anticonvulsivos, y como depresivos antimaníacos, como anestésicos locales, como antiarrítmicos y para el tratamiento o prevención de neuropatía diabética.
ARP020103213A 2001-09-07 2002-08-27 Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento AR037233A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31752601P 2001-09-07 2001-09-07

Publications (1)

Publication Number Publication Date
AR037233A1 true AR037233A1 (es) 2004-11-03

Family

ID=23234074

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103213A AR037233A1 (es) 2001-09-07 2002-08-27 Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento

Country Status (12)

Country Link
US (3) US7105549B2 (es)
EP (1) EP1432419A1 (es)
JP (1) JP2005506981A (es)
KR (1) KR20040031053A (es)
AR (1) AR037233A1 (es)
BR (1) BR0212338A (es)
CA (1) CA2459527A1 (es)
HU (1) HUP0500131A3 (es)
IL (1) IL160716A0 (es)
MX (1) MXPA04002171A (es)
RU (1) RU2004110721A (es)
WO (1) WO2003022276A1 (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04000411A (es) * 2001-07-16 2004-03-18 Euro Celtique Sa Tiazolidinonas arilo sustituidas y uso de las mismas.
AR037233A1 (es) * 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
GB0124939D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124931D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124938D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124941D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124936D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
MXPA04007838A (es) 2002-02-12 2004-10-15 Smithkline Beecham Corp Derivados de nicotamida utiles como inhibidores p38.
DK1483247T3 (da) * 2002-03-13 2009-08-17 Euro Celtique Sa Arylsubstituerede pyrimidiner og anvendelsen deraf
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
BR0313352A (pt) * 2002-07-31 2005-07-12 Euro Celtique Sa Composto, composições farmacêuticas, método para a produção de um composto, método para o tratamento, prevenção ou a melhora de um distúrbio e método para o tratamento de um mamìfero
US20050227974A9 (en) * 2002-08-01 2005-10-13 Euro-Celtique S.A. Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
US20040152696A1 (en) * 2002-08-01 2004-08-05 Euro-Celtique S.A. 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
EP1608622A4 (en) * 2003-03-24 2009-04-01 Merck & Co Inc BIARYLSUBSTITUTED 6-LOW HETEROCYCLES AS SODIUM CHANNEL BLOCKERS
GB0308185D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
CN1922156A (zh) 2003-11-10 2007-02-28 默克公司 作为钠通道阻断剂的取代的***
GB0402143D0 (en) * 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
JP4056081B1 (ja) 2004-07-23 2008-03-05 ファイザー・インク ピリジン誘導体
US20080051416A1 (en) * 2004-10-05 2008-02-28 Smithkline Beecham Corporation Novel Compounds
GB0512429D0 (en) * 2005-06-17 2005-07-27 Smithkline Beecham Corp Novel compound
WO2007011760A2 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
TW200728258A (en) * 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
JP4159586B2 (ja) * 2006-08-03 2008-10-01 エヌイーシーコンピュータテクノ株式会社 情報処理装置および情報処理の高速化方法
BRPI0810202A2 (pt) 2007-05-03 2014-10-21 Pfizer Ltd Derivados de piridina
KR200451955Y1 (ko) * 2008-05-09 2011-01-25 박영주 차량진입 방지대
BRPI0916576A2 (pt) 2008-08-04 2017-06-27 Chdi Inc pelo menos uma entidade química, composição farmacêutica, e, método para tratar uma condição ou distúrbio.
SG182534A1 (en) 2010-01-25 2012-08-30 Chdi Foundation Inc Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US9120752B2 (en) 2010-07-16 2015-09-01 Purdue Pharma, L.P. Pyridine compounds as sodium channel blockers
CA2811479A1 (en) * 2010-09-17 2012-03-22 Purdue Pharma L.P. Pyridine compounds and the uses thereof
KR20130095772A (ko) 2010-10-05 2013-08-28 퍼듀 퍼머 엘피 나트륨 채널 차단제로서 퀴나졸린 화합물
ES2570784T3 (es) 2010-12-22 2016-05-20 Purdue Pharma Lp Piridinas sustituidas como bloqueadores de los canales de sodio
MX364378B (es) 2011-08-30 2019-01-21 Chdi Foundation Inc Inhibidores de la quinurenina-3-monooxigenasa, sus composiciones farmaceuticas y metodos para uso.
EP2751086A4 (en) 2011-08-30 2015-09-16 Chdi Foundation Inc KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHOD OF USE THEREOF
CA2846463C (en) 2011-09-02 2017-10-24 Purdue Pharma L.P. Pyrimidines as sodium channel blockers
WO2013064884A1 (en) * 2011-10-31 2013-05-10 Purdue Pharma L.P. Quaternized amines as sodium channel blockers
AU2012324010A1 (en) 2011-10-31 2013-05-16 Purdue Pharma L.P. Heteroaryl compounds as sodium channel blockers
WO2013072758A1 (en) 2011-11-15 2013-05-23 Purdue Pharma L.P. Pyrimidine diol amides as sodium channel blockers
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
US9143309B2 (en) * 2012-04-13 2015-09-22 Dominant Technologies, LLC Hopping master in wireless conference
WO2014096941A1 (en) 2012-12-20 2014-06-26 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
EP2964639B1 (en) 2013-03-04 2018-05-02 Purdue Pharma LP Pyrimidine carboxamides as sodium channel blockers
US9120786B2 (en) 2013-03-04 2015-09-01 Purdue Pharma, L.P. Triazine carboxamides as sodium channel blockers
CA3082427A1 (en) * 2013-03-15 2014-09-25 Purdue Pharma L.P. Carboxamide derivatives and use thereof
US9884865B2 (en) 2013-08-26 2018-02-06 Purdue Pharma L.P. Azaspiro[4.5] decane derivatives and use thereof
SI3052476T1 (sl) * 2013-09-30 2020-12-31 Guangzhou Innocare Pharma Tech Co., Ltd. Substituirani nikotinimidni inhibitorji BTK in njihova priprava in uporaba pri zdravljenju raka, vnetja in avtoimunske bolezni
US9340504B2 (en) 2013-11-21 2016-05-17 Purdue Pharma L.P. Pyridine and piperidine derivatives as novel sodium channel blockers
EP3083606B1 (en) 2013-12-20 2020-10-28 Purdue Pharma LP Pyrimidines and use thereof
US9695144B2 (en) 2013-12-23 2017-07-04 Purdue Pharma L.P. Dibenzazepine derivatives and use thereof
AU2014370407B2 (en) 2013-12-23 2018-03-29 Purdue Pharma L.P. Indazoles and use thereof
EP3089978B1 (en) 2013-12-30 2018-08-29 Purdue Pharma L.P. Pyridone-sulfone morphinan analogs as opioid receptor ligands
US10047075B2 (en) 2014-01-24 2018-08-14 Purdue Pharma L.P. Pyridines and pyrimidines and use thereof
CA2939501C (en) 2014-02-12 2020-07-07 Purdue Pharma L.P. Isoquinoline derivatives and use thereof
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
EP3139921A4 (en) 2014-05-06 2018-02-14 Purdue Pharma L.P. Benzomorphan analogs and use thereof
JP6360915B2 (ja) 2014-06-13 2018-07-18 パーデュー、ファーマ、リミテッド、パートナーシップ アザモルフィナン誘導体及びその使用
EP3154971A4 (en) 2014-06-13 2017-11-01 Purdue Pharma L.P. Heterocyclic morphinan derivatives and use thereof
MX2017000779A (es) 2014-07-17 2017-07-27 Chdi Foundation Inc Metodos y composiciones para el tratamiento de trastornos relacionados con el vih.
US10081616B2 (en) * 2014-08-28 2018-09-25 X-Chem, Inc. Soluble epoxide hydrolase inhibitors and uses thereof
WO2018125716A1 (en) 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149109A (en) * 1962-02-20 1964-09-15 Searle & Co Certain 4-trifluoromethyl-2-(oxy/thio) pyrimidines
FR1477021A (fr) 1965-04-21 1967-04-14 Ilford Ltd Matières photographiques
GB1121922A (en) * 1966-06-17 1968-07-31 Ici Ltd Pyrimidine derivatives
FR1536093A (fr) 1966-09-10 1968-08-09 Basf Ag Nouvelles amino-4-alcoylmercapto-6-triazines-s
US3631036A (en) * 1969-11-04 1971-12-28 American Home Prod 5-amino-2 6-substituted-7h-pyrrolo(2 3-d) pyrimidines and related compounds
US3660414A (en) * 1970-06-01 1972-05-02 Sandoz Ag Certain 5-aryl-2-amino-nicotinonitriles
US3709888A (en) * 1970-06-01 1973-01-09 Sandoz Ag Aryl-substituted-pyrido(2,3-d)pyrimidin-2-ones
US3940404A (en) * 1974-03-06 1976-02-24 The United States Of America As Represented By The Secretary Of The Army 2-Substituted phenyl-6-trifluoromethyl-4-pyridyl-carbinolamines
US3886167A (en) * 1974-03-06 1975-05-27 Us Army 2-Aryl-6-trifluoromethyl-4-pyridylcarbinolamine antimalarials
DE2643753A1 (de) * 1976-09-29 1978-04-06 Thomae Gmbh Dr K Neue 1h-pyrazolo eckige klammer auf 3,4-b eckige klammer zu pyridine
US4133956A (en) * 1977-07-27 1979-01-09 Eli Lilly And Company Preparation of benzoylureas
US4293552A (en) * 1978-02-27 1981-10-06 Eli Lilly And Company Novel 1-(mono-o-substituted benzoyl)-3-(substituted pyrazinyl) ureas
ES8104268A1 (es) 1979-04-05 1981-04-01 Lilly Industries Ltd Procedimiento para preparar piranonas 5-sustituidas
JPS56104883A (en) 1980-01-25 1981-08-20 Tanabe Seiyaku Co Ltd Novel pyridinecarboxamide derivative and its preparation
JPS56115784A (en) * 1980-02-15 1981-09-11 Tanabe Seiyaku Co Ltd Novel pyridinecarboxamide derivative and its preparation
US4769462A (en) * 1980-06-02 1988-09-06 American Cyanamid Co. Novel 2-carbamoylnicotinic and 3-quinolinecarboxylic acids and esters
GB2095240A (en) 1981-03-05 1982-09-29 Fujisawa Pharmaceutical Co Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
DE3239573A1 (de) 1981-10-28 1983-05-19 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte picolinsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
DE3245950A1 (de) 1981-12-24 1983-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Verfahren zur herstellung substituierter pyridine
FR2527206B1 (fr) 1982-05-18 1986-12-05 Sandoz Sa Nouveaux derives de la 2(1h)-pyridinone, leur preparation et leur utilisation comme medicaments
DE3379544D1 (en) * 1982-06-08 1989-05-11 Ciba Geigy Ag 2-phenyl-2-naphthyl and 2-heterocyclic pyrimidines as antidotes for protecting cultured plants before phytotoxic damages caused by herbicides
FR2531948B1 (fr) * 1982-06-28 1986-05-09 Nat Res Dev Pesticide et procedes pour sa preparation et pour son utilisation
EP0123700A1 (de) 1983-04-27 1984-11-07 Byk Gulden Lomberg Chemische Fabrik GmbH Substituierte Picolinsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
US4701208A (en) * 1983-08-02 1987-10-20 American Cyanamid Company Dihydroimidazopyrrolopyridine, quinoline, thieno- and furo[2,3-b]pyridine, dihydrothieno- and furo[2,3-b]-pyridine, thieno- and furo[3,2-b]pyridine and dihydrothieno- and furo[3,2-b]pyridine herbicides and method for preparation thereof
SU1790172A1 (ru) 1984-05-17 1995-05-10 Всесоюзный Государственный Научно-Исследовательский И Проектный Институт Химико-Фотографической Промышленности Бисчетвертичные соли пиридина в качестве активаторов спектральной сенсибилизации фотографических бромйодсеребряных эмульсий, содержащих анионные или катион-анионные цианины
DE3685840D1 (de) 1985-04-30 1992-08-06 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
GB8531637D0 (en) 1985-12-23 1986-02-05 Ici Plc Pyrimidine derivatives
US4962109A (en) * 1985-12-23 1990-10-09 Imperial Chemical Industries Plc Insecticidally and acaricidally active pyrimidine esters and intermediates therefor
JPS6320234A (ja) 1986-07-11 1988-01-27 Daihatsu Motor Co Ltd 自動車の２輪・４輪駆動切換装置
PH23565A (en) * 1986-09-05 1989-08-25 Sumitomo Chemical Co Novel pyrimidinylpyrimidine derivatives and a plant disease protectant containing them as the active ingredient
GB8627059D0 (en) 1986-11-12 1986-12-10 Cookson Group Plc Substituted trialine derivatives
ZW21687A1 (en) * 1986-12-12 1988-07-20 Hoffmann La Roche Triazine derivatives
US5116989A (en) * 1987-11-06 1992-05-26 Baxter Diagnostics Inc. Fluorescent poly(arylpyridine) rare earth chelates
US5084462A (en) * 1988-04-26 1992-01-28 The Du Pont Merck Pharmaceutical Company 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents
DE68905884T2 (de) * 1988-07-13 1993-08-12 Canon Kk Ferroelektrische, chirale, smektische fluessigkristall-zusammensetzung und vorrichtung zu deren anwendung.
JPH0252360A (ja) 1988-08-15 1990-02-21 Fujitsu Ltd 電子写真感光体
EP0362578A1 (en) 1988-09-14 1990-04-11 E.I. Du Pont De Nemours And Company Treatment of cancer in mammals by concurrent administration of 4-quinoline carboxylic acid derivatives and interleukin-2
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
GB8918893D0 (en) 1989-08-18 1989-09-27 Wellcome Found Pharmacologically active cns compounds
US4968702A (en) * 1989-01-17 1990-11-06 American Cyanamid Company Substituted quinolinecarboxylic acids
GB8906470D0 (en) 1989-03-21 1989-05-04 Cookson Group Plc Photopolymerisable composition
DE4134467A1 (de) * 1991-10-18 1993-04-22 Thomae Gmbh Dr K Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
WO1990015673A1 (en) * 1989-06-12 1990-12-27 General Electric Company A laminar impressor for coating flat substrates
DE3940476A1 (de) * 1989-12-07 1991-06-13 Bayer Ag Pyridinylpyrimidin-derivate
GB8923131D0 (en) 1989-10-13 1989-11-29 Smith Kline French Lab Chemical compounds
US5136080A (en) * 1989-12-04 1992-08-04 Burroughs Wellcome Co. Nitrile compounds
US5403934A (en) * 1990-03-12 1995-04-04 Burroughs Wellcome Co. Heterocyclic compounds
EP0446604A3 (en) 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents
JPH06501254A (ja) 1990-09-28 1994-02-10 スミス・クライン・アンド・フレンチ・ラボラトリース・リミテッド 医薬用フェニルピリジノール誘導体
DE4032147A1 (de) 1990-10-10 1992-04-16 Bayer Ag Verwendung von substituierten 2-mercaptonicotinsaeurederivaten zur bekaempfung von endoparasiten, neue substituierte 2-mercaptonicotinsaeurederivate und verfahren zu ihrer herstellung
WO1992007846A1 (en) 1990-10-25 1992-05-14 Kumiai Chemical Industry Co., Ltd. Picolinic acid derivative, production thereof, and herbicide
JPH0597706A (ja) 1991-04-09 1993-04-20 Chemex Block Drug Jv アフタ性潰瘍および他の粘膜皮膚障害の処置方法
GB9124578D0 (en) 1991-11-20 1992-01-08 Smithkline Beecham Plc Chemical compounds
DE4200323A1 (de) 1992-01-09 1993-07-15 Bayer Ag Herbizide und pflanzennematizide mittel auf basis von mercaptonicotinsaeurederivaten
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
TW237456B (es) * 1992-04-09 1995-01-01 Ciba Geigy
JPH0776542A (ja) 1993-09-06 1995-03-20 Canon Inc 液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置
US5602156A (en) * 1993-09-17 1997-02-11 The United States Of America As Represented By The Department Of Health And Human Services Method for inhibiting metalloproteinase expression
US5744492A (en) * 1993-09-17 1998-04-28 United States Of America Method for inhibiting angiogenesis
IL112290A (en) 1994-01-12 1999-01-26 Novartis Ag Transformed aryl and the troiryl pyrimidines and herbicides containing them
GB9405347D0 (en) * 1994-03-18 1994-05-04 Agrevo Uk Ltd Fungicides
US5563143A (en) 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
US6057346A (en) * 1994-12-12 2000-05-02 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of retroviral LTR promoters by calcium response modifiers
CZ290330B6 (cs) * 1995-01-26 2002-07-17 American Cyanamid Company 2,6-Disubstituované pyridinové a 2,4-disubstituované pyrimidinové deriváty, způsob a meziprodukty pro jejich výrobu, jejich pouľití a herbicidní prostředky na jejich bázi a způsob potlačování růstu neľádoucích rostlin
US5849758A (en) * 1995-05-30 1998-12-15 American Cyanamid Company Herbicidal 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines
US6008161A (en) * 1995-05-30 1999-12-28 American Cyanamid Company Herbicidal 2-(hetero)aryloxy-6-arylpyridines and 2-aryl-4-(hetero) aryloxypyrimidines
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
DE69616364T2 (de) * 1995-08-02 2002-07-11 Smithkline Beecham Corp Endothelinrezeptorantagonisten
WO1998037068A1 (en) * 1997-02-21 1998-08-27 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
KR20010020201A (ko) 1997-04-22 2001-03-15 코센시스 인크 탄소고리 및 헤테로고리 치환된 세미카르바존 및 티오세미카르바존과 그들의 사용 방법
ATE239012T1 (de) 1997-12-12 2003-05-15 Abbott Lab Triazin angiogenese-inhibitoren
JP4321737B2 (ja) 1997-12-17 2009-08-26 塩野義製薬株式会社 新規ピリジン化合物
US6166006A (en) 1997-12-19 2000-12-26 Takeda Chemical Industries, Ltd. Anilide derivative, production and use thereof
WO1999038829A1 (fr) 1998-01-28 1999-08-05 Shionogi & Co., Ltd. Nouveau compose tricyclique
AU1409100A (en) 1998-11-27 2000-06-19 Takeda Chemical Industries Ltd. Drugs
EP1140901A2 (en) 1998-12-24 2001-10-10 Aventis Pharmaceuticals Products Inc. Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
US6414011B1 (en) * 1999-03-26 2002-07-02 Euro-Celtique S.A. Aryl substituted pyrazoles, and pyrroles, and the use thereof
JP2003511378A (ja) * 1999-10-07 2003-03-25 アムジエン・インコーポレーテツド トリアジン系キナーゼ阻害薬
DOP2000000109A (es) * 1999-12-23 2002-08-30 Gerald Kleymann Derivados de tiazolilamida
AU779442B2 (en) 2000-01-20 2005-01-27 Eisai Co. Ltd. Novel piperidine compounds and drugs containing the same
AR029489A1 (es) * 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
ES2398093T3 (es) * 2000-03-24 2013-03-13 Euro-Celtique S.A. Pirazoles, triazoles y tetrazoles sustituidos con arilo como bloqueantes de los canales de sodio
EP1268427A1 (en) * 2000-03-31 2003-01-02 Cocensys, Inc. Aminopyridines and their use as anticonvulsants and sodium channel blockers
JP4272338B2 (ja) 2000-09-22 2009-06-03 バイエル アクチェンゲゼルシャフト ピリジン誘導体
US6394753B1 (en) * 2001-02-07 2002-05-28 Hypro Corporation Flexible impeller removal and installation method
US6552188B2 (en) * 2001-06-29 2003-04-22 Kowa Co., Ltd. Unsymmetrical cyclic diamine compound
US6395753B1 (en) * 2001-08-30 2002-05-28 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
DK1483247T3 (da) * 2002-03-13 2009-08-17 Euro Celtique Sa Arylsubstituerede pyrimidiner og anvendelsen deraf

Also Published As

Publication number Publication date
JP2005506981A (ja) 2005-03-10
CA2459527A1 (en) 2003-03-20
HUP0500131A3 (en) 2005-07-28
US20070010554A1 (en) 2007-01-11
EP1432419A1 (en) 2004-06-30
US7579367B2 (en) 2009-08-25
US20030055088A1 (en) 2003-03-20
WO2003022276A1 (en) 2003-03-20
US7943643B2 (en) 2011-05-17
BR0212338A (pt) 2004-09-21
US20100048626A1 (en) 2010-02-25
MXPA04002171A (es) 2004-07-23
US20080194627A9 (en) 2008-08-14
HUP0500131A2 (hu) 2005-05-30
IL160716A0 (en) 2004-08-31
RU2004110721A (ru) 2005-10-10
US7105549B2 (en) 2006-09-12
KR20040031053A (ko) 2004-04-09

Similar Documents

Publication Publication Date Title
AR037233A1 (es) Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
AR029489A1 (es) Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
CA2400778A1 (en) Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
MX2022014458A (es) Derivados de triazina que tienen actividad inhibidora de la replicacion del virus y composicion farmaceutica que constituye el mismo.
AR060545A1 (es) Compuestos de benzoaxol y benzotiazol 6-0- sustituidos y metodos de inhibicion de la senalizacion de csf-1r. composiciones farmaceuticas
AR065499A1 (es) Inhibidores de serino proteasas.composiciones farmaceuticas
FI811897L (fi) Foerfarande foer framstaellning av aryloxipropanolaminer
AR053232A1 (es) Derivados de piridina condensadas, composiciones farmaceuticas que los contienen y su empleo en la fabricacion de agentes terapeuticos antiinflamatorios y para el tratamiento de enfermedades relacionadas con el sistema inmunologico.
LV12209A (lv) Ar fenilgrupu aizvietoti heterocikli ka ciklooksigenazes-2 inhibitori
IL108562A (en) 7, 8-diaryl-1,2,3,4- terahydropyrazolo- £5,1-c| £1,2,4| triazine derivatives, methods for the preparation thereof and pharmaceutical compositions containing them
LTIP846A (en) N-(4-piperidinyl)(dihydrobenzofuran or dihydro-2h-benzopyran)carboxamide derivatives,processes for the preparation thereof and pharmaceutical compositions
RU2006147307A (ru) Производные 3-карбамоил-2-пиридона
MY136800A (en) Inhibitors of the interaction between mdm2 and p53
HUP0401819A2 (hu) Proteinkináz inhibitorokként alkalmazható pirazolvegyületek és ezeket tartalmazó gyógyszerkészítmények
NO933452L (no) Et terapeutisk middel for Parkinson's sykdom
HUP0303825A2 (hu) 1H-Benzimidazol- és 3h-imidazo-[4,5b]piridin-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ES8505972A1 (es) Un procedimiento para preparar derivados de pirimidina
HRP20080119T3 (en) Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
FI863488A (fi) Foereningar.
RS111104A (en) 1-/(indol-3-yl)carbonyl/piperazine derivatives
BG104717A (en) Water soluble azoles as broad-spectrum antifungals
BRPI0409374A (pt) composto, composição farmacêutica, uso de pelo menos um composto, e, método para o tratamento de um distúrbio médico
MXPA05010651A (es) Compuestos de pirazol.
AR024146A1 (es) Derivados de 4-fenil-pirimidina

Legal Events

Date Code Title Description
FB Suspension of granting procedure